BioNet at World Vaccine Congress, 22-24 April 2025
Discover what’s next in pertussis prevention with BioNet at the World Vaccine Congress in Washington D.C.
Join us on April 23 at 15:55 for a presentation on our latest innovation “Recombinant acellular pertussis vaccine for long-lasting protection.”
Connect with Bill Cadwallader, VP of Business Operations North America, and Dr. Wassana Wijagkanalan, Director of Discovery, to explore BioNet’s vaccine innovation and opportunities for collaboration.